Published on in Vol 11, No 5 (2022): May

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/35969, first published .
Developing Reporting Guidelines for Studies of HIV Drug Resistance Prevalence: Protocol for a Mixed Methods Study

Developing Reporting Guidelines for Studies of HIV Drug Resistance Prevalence: Protocol for a Mixed Methods Study

Developing Reporting Guidelines for Studies of HIV Drug Resistance Prevalence: Protocol for a Mixed Methods Study

Journals

  1. Mbuagbaw L, Garcia C, Brenner B, Cecchini D, Chakroun M, Djiadeu P, Holguin A, Mor O, Parkin N, Santoro M, Ávila-Ríos S, Fokam J, Phillips A, Shafer R, Jordan M. Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended use. The Lancet HIV 2023;10(10):e684 View
  2. Garcia C, Holbrook A, Djiadeu P, Alvarez E, Matos Silva J, Mbuagbaw L. Developing a reporting item checklist for studies of HIV drug resistance prevalence or incidence: a mixed methods study. BMJ Open 2024;14(3):e080014 View
  3. Ngo H, Pham T, Hoang H, Bui D, Phan H, Nguyen Q, Duong T, Bui H, Nguyen H, Le M, Dang A, McFarland W, Truong H, Pham T. Detection of Antiretroviral Drug-Resistant Mutations and HIV-1 Subtypes in Circulation Among Men Who Have Sex With Men, SEM Females, and Female Sex Workers: Results of Vietnam's HIV Sentinel Surveillance Plus System, 2018–2020. JAIDS Journal of Acquired Immune Deficiency Syndromes 2025;98(1):29 View